
### [NCIT:C27233](http://purl.obolibrary.org/obo/NCIT_C27233)
**Label:** Transplant-Related Disorder

**Subclasses:** [NCIT:C27696](http://purl.obolibrary.org/obo/NCIT_C27696) (EBV-Related Post-Transplant Lymphoproliferative Disorder), [NCIT:C27695](http://purl.obolibrary.org/obo/NCIT_C27695) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder), [NCIT:C27233](http://purl.obolibrary.org/obo/NCIT_C27233) (Transplant-Related Disorder), [NCIT:C27632](http://purl.obolibrary.org/obo/NCIT_C27632) (Transplant-Related Malignant Neoplasm), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C27638](http://purl.obolibrary.org/obo/NCIT_C27638) (Transplant-Related Renal Cell Carcinoma), [NCIT:C27637](http://purl.obolibrary.org/obo/NCIT_C27637) (Transplant-Related Lung Carcinoma), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C27639](http://purl.obolibrary.org/obo/NCIT_C27639) (Transplant-Related Hematologic Malignancy), [NCIT:C7246](http://purl.obolibrary.org/obo/NCIT_C7246) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C27634](http://purl.obolibrary.org/obo/NCIT_C27634) (Transplant-Related Bladder Urothelial Carcinoma), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C27633](http://purl.obolibrary.org/obo/NCIT_C27633) (Transplant-Related Carcinoma), [NCIT:C7243](http://purl.obolibrary.org/obo/NCIT_C7243) (Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder), [NCIT:C27636](http://purl.obolibrary.org/obo/NCIT_C27636) (Transplant-Related Skin Squamous Cell Carcinoma), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), [NCIT:C27635](http://purl.obolibrary.org/obo/NCIT_C27635) (Transplant-Related Hepatocellular Carcinoma), [NCIT:C27640](http://purl.obolibrary.org/obo/NCIT_C27640) (Transplant-Related Kaposi Sarcoma), [NCIT:C7238](http://purl.obolibrary.org/obo/NCIT_C7238) (Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7237](http://purl.obolibrary.org/obo/NCIT_C7237) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7239](http://purl.obolibrary.org/obo/NCIT_C7239) (Hodgkin-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7233](http://purl.obolibrary.org/obo/NCIT_C7233) (Monomorphic Post-Transplant Lymphoproliferative Disorder), [NCIT:C7232](http://purl.obolibrary.org/obo/NCIT_C7232) (Neoplastic Post-Transplant Lymphoproliferative Disorder), [NCIT:C7183](http://purl.obolibrary.org/obo/NCIT_C7183) (Polymorphic Post-Transplant Lymphoproliferative Disorder), [NCIT:C4727](http://purl.obolibrary.org/obo/NCIT_C4727) (Post-Transplant Lymphoproliferative Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C27233](http://purl.obolibrary.org/obo/NCIT_C27233) (Transplant-Related Disorder) 98.33%
- [NCIT:C35686](http://purl.obolibrary.org/obo/NCIT_C35686) (Immunodeficiency-Related Disorder) 95.93%
- [NCIT:C27233](http://purl.obolibrary.org/obo/NCIT_C27233) (Transplant-Related Disorder) and [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 93.33%
- [NCIT:C27351](http://purl.obolibrary.org/obo/NCIT_C27351) (Immune System and Related Disorders) 92.60%
- [NCIT:C27233](http://purl.obolibrary.org/obo/NCIT_C27233) (Transplant-Related Disorder) and [NCIT:C7062](http://purl.obolibrary.org/obo/NCIT_C7062) (Neoplasm by Special Category) 91.67%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) and [NCIT:C35686](http://purl.obolibrary.org/obo/NCIT_C35686) (Immunodeficiency-Related Disorder) 91.51%
- [NCIT:C27632](http://purl.obolibrary.org/obo/NCIT_C27632) (Transplant-Related Malignant Neoplasm) 90.00%
- [NCIT:C35686](http://purl.obolibrary.org/obo/NCIT_C35686) (Immunodeficiency-Related Disorder) and [NCIT:C4969](http://purl.obolibrary.org/obo/NCIT_C4969) (Therapy-Related Malignant Neoplasm) 90.00%
- [NCIT:C35686](http://purl.obolibrary.org/obo/NCIT_C35686) (Immunodeficiency-Related Disorder) and [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 90.00%
- [NCIT:C3487](http://purl.obolibrary.org/obo/NCIT_C3487) (Therapy-Related Neoplasm) and [NCIT:C35686](http://purl.obolibrary.org/obo/NCIT_C35686) (Immunodeficiency-Related Disorder) 90.00%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) and [NCIT:C35686](http://purl.obolibrary.org/obo/NCIT_C35686) (Immunodeficiency-Related Disorder) 90.00%
- [NCIT:C27936](http://purl.obolibrary.org/obo/NCIT_C27936) (Immunodeficiency-Related Neoplasm) and [NCIT:C4969](http://purl.obolibrary.org/obo/NCIT_C4969) (Therapy-Related Malignant Neoplasm) 90.00%
- [NCIT:C27936](http://purl.obolibrary.org/obo/NCIT_C27936) (Immunodeficiency-Related Neoplasm) and [NCIT:C3487](http://purl.obolibrary.org/obo/NCIT_C3487) (Therapy-Related Neoplasm) 90.00%
- [NCIT:C27770](http://purl.obolibrary.org/obo/NCIT_C27770) (Immunodeficiency-Related Malignant Neoplasm) and [NCIT:C4969](http://purl.obolibrary.org/obo/NCIT_C4969) (Therapy-Related Malignant Neoplasm) 90.00%
- [NCIT:C27770](http://purl.obolibrary.org/obo/NCIT_C27770) (Immunodeficiency-Related Malignant Neoplasm) and [NCIT:C3487](http://purl.obolibrary.org/obo/NCIT_C3487) (Therapy-Related Neoplasm) 90.00%


